A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 Mg Daily) in Post Menopausal Women With Parkinson's Disease

Trial Profile

A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 Mg Daily) in Post Menopausal Women With Parkinson's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Acronyms POETRY
  • Most Recent Events

    • 07 Jan 2008 Status changed from in progress to completed.
    • 16 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top